Compare · FHLT vs HIMS
FHLT vs HIMS
Side-by-side comparison of Future Health ESG Corp. (FHLT) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FHLT and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS carries a market cap of $7.58B.
- HIMS has hit the wire 6 times in the past 4 weeks while FHLT has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 0 for FHLT).
- Company
- Future Health ESG Corp.
- Hims & Hers Health Inc.
- Price
- $11.38+6.45%
- $32.73+0.08%
- Market cap
- -
- $7.58B
- 1M return
- -
- -7.70%
- 1Y return
- -
- -31.25%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2019
- News (4w)
- 0
- 6
- Recent ratings
- 0
- 25
Future Health ESG Corp.
Future Health ESG Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Dover, Delaware.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest FHLT
- Future Health ESG Corp. filed SEC Form 8-K: Leadership Update
- SEC Form NT 10-Q/A filed by Future Health ESG Corp. (Amendment)
- Future Health ESG Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Polar Asset Management Partners Inc. sold $14,947 worth of shares (1,255 units at $11.91) (SEC Form 4)
- SEC Form NT 10-Q filed by Future Health ESG Corp.
- SEC Form SC 13D filed by Future Health ESG Corp.
- Future Health Esg Associates 1, Llc sold 1,703,486 shares, decreasing direct ownership by 65% to 921,514 units (SEC Form 4)
- Morgan Travis A sold 2,079,245 shares (SEC Form 4)
- Bostic Bradley sold 2,079,245 shares (SEC Form 4)
- SEC Form SC 13G/A filed by Future Health ESG Corp. (Amendment)
Latest HIMS
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $229,168 worth of shares (7,163 units at $31.99) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
- Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update
- Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax
- Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)